Interview with Shivani Wagh, Joint Managing Director, Supriya Lifescience Ltd
Interview with Shivani Wagh, Joint Managing Director, Supriya Lifescience Ltd

Interview with Shivani Wagh, Joint Managing Director, Supriya Lifescience Ltd

In this insightful interview, Shivani Wagh, Joint Managing Director of Supriya Lifescience Ltd, discusses the company's recent impressive financial performance, strategies for sustained growth, and the evolving landscape of the Indian pharmaceutical industry.

Mandar Wagh Article rating: 4.4

In this insightful interview, Shivani Wagh, Joint Managing Director of Supriya Lifescience Ltd, discusses the company's recent impressive financial performance, strategies for sustained growth, and the evolving landscape of the Indian pharmaceutical industry.

 

In an interaction with Dr Saloni Wagh, Director of Supriya Lifescience Ltd
In an interaction with Dr Saloni Wagh, Director of Supriya Lifescience Ltd

In an interaction with Dr Saloni Wagh, Director of Supriya Lifescience Ltd

Establishing a strong regulatory framework and maintaining compliance with relevant regulations is paramount for success in the pharmaceutical industry, states Dr Saloni Wagh, Director of Supriya Lifescience Ltd.

Mandar Wagh Article rating: 4.6

Establishing a strong regulatory framework and maintaining compliance with relevant regulations is paramount for success in the pharmaceutical industry, states Dr Saloni Wagh, Director of Supriya Lifescience Ltd.

RSS

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR